Masaki N, Hayashi S, Maruyama T, Okabe H, Matsukawa M, Unno J, Maekawa S, Oka T, Tani M, Matsueda K
Division of Gastroenterology, National Medical Center, Tokyo, Japan.
Cancer Chemother Pharmacol. 1994;33 Suppl:S7-11. doi: 10.1007/BF00686660.
Two patients with advanced hepatocellular carcinoma presented severe exertional dyspnea because of extension of a tumor into the right side of the heart. Removable of the tumor thrombus by open-heart surgery ameliorated the symptoms in each case, but their subsequent courses differed considerably. One patient survived for as long as 8 months thanks to successive multi-disciplinary treatments, whereas the other patient died suddenly 1 month after the surgery. The first patient's hepatocellular carcinoma was more differentiated, and the dyspnea was caused by a low cardiac output due to the intracardiac tumor mass, not by pulmonary embolism as in the second patient's case. We conclude that successive multidisciplinary treatments to control the growth of hepatocellular carcinoma is the most important approach and is indispensable for improving the prognosis.
两名晚期肝细胞癌患者因肿瘤延伸至心脏右侧而出现严重劳力性呼吸困难。通过心脏直视手术切除肿瘤血栓在每种情况下都改善了症状,但他们随后的病程差异很大。一名患者由于连续的多学科治疗存活了长达8个月,而另一名患者在手术后1个月突然死亡。第一名患者的肝细胞癌分化程度更高,呼吸困难是由心内肿瘤团块导致的心输出量降低引起的,而不像第二名患者那样是由肺栓塞引起的。我们得出结论,连续的多学科治疗以控制肝细胞癌的生长是最重要的方法,对于改善预后不可或缺。